Breast imaging is a technique used to obtain high resolution visualization of breast tissues and associated diseases. Breast cancer is the leading cause of the breast disease that require immediate screening, which in turn is anticipate to boost growth of the breast imaging market.
Breast cancer can occur both in men and women. Furthermore, it is majorly reported in females as compared to male. The most common breast imaging tests used to determine breast cancer and related disease are ultrasound, mammography, nuclear imaging MRI, and thermography. Furthermore, mammography is the most preferred imaging techniques for breast cancer diagnosis for the women of age 40 and above.
The global breast imaging market size was valued at US$ 3,150.3 million in 2017, and is expected to witness a CAGR of 9.9% over the forecast period (2018 – 2026).

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2040

Increasing number of accidents and growing geriatric population are expected to drive growth of the breast imaging market
Increasing incidence of breast cancer is expected to be a major factor driving growth of the breast imaging market during the forecast period. According to the breastcancer.org, around 1 in 8 women develop breast cancer over the course of their lifetime. According to the same source, in 2017, an estimated 252,710 new cases of invasive breast cancer are expected to be diagnosed among women in the U.S.
Increasing government initiatives such as awareness programs and funding for research and development to introduce advanced imaging technologies in the market are expected to propel the breast imaging market growth.
For instance, in 2013, Avon Foundation, in partnership with NCI (National Cancer Institute) and the Center for Advancing Innovation funded US$ 250,000 to launch the Breast Cancer Start-up Challenge aimed at teams of business, engineering, medical/scientific, and computer science students, as well as small sized entrepreneurs to develop and commercialize advanced breast cancer inventions.
However, side effects of radiation and installation cost of breast cancer imaging devices and facilities may hinder growth of the breast imaging market.

Detailed Segmentation:
• Global Breast Imaging Market, By Technology:
◦ Ionizing Breast Imaging Technology
▪ Analog Mammography
▪ Full Field Digital Mammography (FFDM)
▪ 3D Breast Tomosynthesis
▪ Positron Emission Tomography/ Computed Tomography (PET/CT)
▪ Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI)
▪ Positron Emission Mammography
▪ Others
◦ Non-Ionizing Breast Imaging Technology
▪ Breast MRI (Magnetic Resonance Imaging)
▪ Breast Ultrasound
▪ Optical Imaging
▪ Automated Whole Breast Ultrasound (AWBU)
▪ Breast Thermography
• Global Breast Imaging Market, By End User:
◦ Hospitals
◦ Diagnostic Laboratories
◦ Ambulatory Surgical Centers

Key Players: Hologic, Inc., General Electric Company, Siemens AG, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.

Request Customization: https://www.coherentmarketinsights.com/insight/request-customization/2040

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]